The development of a non-invasive prenatal diagnostic test using fetal nucleated red blood cells (NRBCs) isolated from the maternal circulation is hampered by the low frequency of these cells in maternal blood, requiring extensive enrichment procedures before any analytical procedure can be performe
DEVELOPMENT OF A MODEL SYSTEM TO COMPARE CELL SEPARATION METHODS FOR THE ISOLATION OF FETAL CELLS FROM MATERNAL BLOOD
β Scribed by DIANA W. BIANCHI; KATHERINE W. KLINGER; THERESA J. VADNAIS; MARY ANN DEMARIA; ANTHONY P. SHUBER; JOEL SKOLETSKY; PAT MIDURA; MATTHEW DIRISO; CHRISTINE PELLETIER; MICHELLE GENOVA; MARLENA S. ERIKSON; JOHN M. WILLIAMS
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 648 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0197-3851
No coin nor oath required. For personal study only.
β¦ Synopsis
Three major methods have been described for the isolation of fetal cells from maternal blood: fluorescenceactivated cell sorting (FACS), immunomagnetic beads, and magnetic-activated cell sorting (MACS). To date, no study has directly compared fetal cell recovery using each of these methods. Here we describe our system using a 'model' male fetal cell mixed into female peripheral blood mononuclear cells. Fetal cell yields and purities were assayed by a quantitative polymerase chain reaction (qPCR) using chromosomes Yand 7-specific sequences. Fetal cell recovery was investigated by selection of CD71' cells or depletion of CD45' cells. Our data demonstrated variation in fetal cell recovery for all methods tested, although CD71' selection by FACS gave the best and most consistent results.
π SIMILAR VOLUMES
Prenatal diagnosis of genetic disorders in nucleated fetal red blood cells present in maternal blood requires methods to detect and enrich for such cells. Here we describe a rapid high performance liquid chromatography (HPLC) method that allows one to determine as few as 100 cells containing haemogl
The purpose of this study was to improve recovery of fetal nucleated erythrocytes (NRBCs) from maternal blood for non-invasive prenatal diagnosis. Peripheral blood samples were obtained from 27 women who had just undergone pregnancy termination at 6 to 23 weeks. Samples were split and mononuclear ce